As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
Mallinckrodt Pharmaceuticals is a $2.1 billion global pharmaceutical company specializing in generic and branded pharmaceuticals, medical imaging, nuclear imaging and contrast media and devices.
As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.
As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.
As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.